iShares 7-10 Year Treasury Bond ETF (NASDAQ:IEF – Get Free Report) was the recipient of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 16,430,000 shares, a growth of 15.9% from the October 15th total of 14,180,000 shares. Based on an average daily volume of 7,931,300 shares, the short-interest ratio is currently 2.1 days.
iShares 7-10 Year Treasury Bond ETF Trading Up 0.0 %
Shares of iShares 7-10 Year Treasury Bond ETF stock opened at $93.32 on Monday. The firm’s 50 day moving average is $96.22 and its 200 day moving average is $95.26. The firm has a market capitalization of $33.15 billion, a PE ratio of -21.67 and a beta of 0.05. iShares 7-10 Year Treasury Bond ETF has a 1 year low of $91.02 and a 1 year high of $99.18.
iShares 7-10 Year Treasury Bond ETF Increases Dividend
The company also recently disclosed a monthly dividend, which was paid on Wednesday, November 6th. Investors of record on Friday, November 1st were issued a dividend of $0.2916 per share. This is an increase from iShares 7-10 Year Treasury Bond ETF’s previous monthly dividend of $0.29. The ex-dividend date of this dividend was Friday, November 1st. This represents a $3.50 annualized dividend and a dividend yield of 3.75%.
Institutional Investors Weigh In On iShares 7-10 Year Treasury Bond ETF
iShares 7-10 Year Treasury Bond ETF Company Profile
iShares 7-10 Year Treasury Bond ETF (the Fund) is an is an exchange-traded fund. The Fund seeks to track the investment results of an index composed of the United States Treasury bonds with remaining maturities between seven and ten years. The Fund seeks to track the investment results of the Barclays U.S.
Read More
- Five stocks we like better than iShares 7-10 Year Treasury Bond ETF
- How to Use the MarketBeat Excel Dividend Calculator
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Stock Sentiment Analysis: How it Works
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for iShares 7-10 Year Treasury Bond ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares 7-10 Year Treasury Bond ETF and related companies with MarketBeat.com's FREE daily email newsletter.